Ann: Imugene appoints experienced life sciences CFO Mike Tonroe, page-19

"Our vision is to help transform and improve the treatment of cancer and the lives of the millions of patients who need effective treatments. This vision is backed by a growing body of clinical evidence and peer-reviewed research. Imugene is well funded and resourced, to deliver on its commercial and clinical milestones. Together with leading specialists and medical professionals, we believe Imugene’s immunooncology therapies will become foundation treatments for cancer. Our goal is to ensure that Imugene and its shareholders are at the forefront of this rapidly growing global market."

The above paragraph is from the announcement on the second page. If you have been following the IMU story, and I am sure you have, then you will notice this has all been planned. And looks like now, IMU is at the pointy end of a commercial and clinical milestone. Hence the appointment of said CFO.

And you know what! I love it when things go according to plan.